Mereo BioPharma Group plc (MREO)
Nasdaq · Pharmaceutical Preparations · Inc. X0
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Mereo BioPharma Group plc. Most notable: 2026-08-11: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing acquisition or disposition of assets
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-09-13 | Scots-Knight Denise | director | S | 60,046 | 4.22 | $253,394 |
| 2024-09-13 | Lewicki John A. | officer | S | 10,937 | 4.22 | $46,154 |
| 2024-09-13 | Sermon Charles | officer | S | 20,946 | 4.22 | $88,392 |
| 2024-09-13 | Fox Christine Ann | officer | S | 19,158 | 4.22 | $80,847 |
| 2024-09-13 | Hughes-Wilson Alexandra | officer | S | 84,008 | 4.22 | $354,514 |
| 2024-09-13 | Hughes-Wilson Alexandra | officer | S | 16,304 | 4.22 | $68,803 |
| 2024-09-12 | Scots-Knight Denise | director | S | 28,611 | 4.47 | $127,891 |
| 2024-09-12 | Lewicki John A. | officer | S | 5,212 | 4.47 | $23,298 |
| 2024-09-12 | Sermon Charles | officer | S | 9,980 | 4.47 | $44,611 |
| 2024-09-12 | Fox Christine Ann | officer | S | 9,128 | 4.47 | $40,802 |
| 2024-09-12 | Hughes-Wilson Alexandra | officer | S | 40,029 | 4.47 | $178,930 |
| 2024-09-12 | Hughes-Wilson Alexandra | officer | S | 7,769 | 4.47 | $34,727 |
| 2024-09-11 | Sermon Charles | officer | M | 65,600 | 0 | $0 |
| 2024-09-11 | Fox Christine Ann | officer | M | 60,000 | 0 | $0 |
| 2024-09-11 | Lewicki John A. | officer | M | 46,000 | 0 | $0 |
| 2024-09-11 | Scots-Knight Denise | director | M | 188,060 | 0 | $0 |
| 2024-09-11 | Hughes-Wilson Alexandra | officer | M | 93,333 | 1.4 | $130,666 |
| 2024-09-11 | Hughes-Wilson Alexandra | officer | M | 40,000 | 0 | $0 |
| 2024-09-11 | Hughes-Wilson Alexandra | officer | M | 75,000 | 1.01 | $75,750 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | director | M | 43,485 | 0.94 | $40,876 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | director | M | 2,071 | 3.87 | $8,015 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | director | M | 12,418 | 2.72 | $33,777 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | director | M | 38,953 | 1.31 | $51,028 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | director | M | 6,492 | 1.84 | $11,945 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | director | S | 105,244 | 4.43 | $466,231 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | director | M | 1,825 | 3 | $5,475 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-19 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-11 10-Q
- 2026-08-11 8-K
- 2026-08-11 8-K
- 2026-05-15 SCHEDULE 13G/A
- 2026-05-14 SCHEDULE 13G
- 2026-05-14 8-K
- 2026-05-12 8-K/A
- 2026-05-12 10-Q
- 2026-05-12 8-K
- 2026-04-09 ARS
- 2026-04-09 DEF 14A
- 2026-03-27 PRE 14A
- 2026-03-27 8-K
- 2026-03-19 10-K
- 2026-03-19 8-K
- 2026-02-27 4
- 2026-02-27 4
- 2026-02-27 4